Aster DM Healthcare Ltd Annual Results: Standalone & Consolidated Reports

Annual Results

Results Snapshot

Figures in Cr

Consolidate Annual Results

Mar'26

Mar'25

Mar'24

Mar'23

Mar'22

Mar'21

Mar'20

Net Sales

4,643.22

4,138.46

3,698.90

2,994.05

10,253.28

8,608.43

8,651.88

Other Operating Income

0.00

Total Operating income

4,643.22

4,138.46

3,698.90

2,994.05

10,253.28

8,608.43

8,651.88

Raw Material Cost

0.00

Purchase of Finished goods

1,047.61

920.16

927.50

805.63

3,068.46

2,436.95

2,768.05

(Increase) / Decrease In Stocks

1.18

18.17

-11.63

-26.42

-176.69

111.96

-228.79

Employee Cost

848.09

760.39

675.93

541.92

3,264.46

2,755.36

2,903.93

Power Cost

0.00

Manufacturing Expenses

27.52

29.21

24.07

22.01

814.77

643.42

688.83

Selling and Distribution Expenses

1,031.87

921.17

815.62

647.29

254.73

275.90

33.64

Other Expenses

785.92

724.83

689.46

554.54

1,544.30

1,322.05

1,228.61

Total Expenditure (Excl Depreciation)

3,742.19

3,373.93

3,120.95

2,544.97

8,770.03

7,545.64

7,394.27

Operating Profit (PBDIT) excl Other Income

901.03

764.53

577.95

449.08

1,483.25

1,062.79

1,257.61

Other Income

125.60

148.23

24.85

36.90

50.66

49.97

37.87

Operating Profit (PBDIT)

1,026.63

912.76

602.80

485.98

1,533.91

1,112.76

1,295.48

Interest

122.98

123.81

110.30

87.26

257.02

293.66

359.67

Exceptional Items

-32.71

5,021.06

6.88

315.90

0.00

-19.64

Gross Profit (PBDT)

870.94

738.81

492.50

398.72

1,276.89

819.10

916.17

Depreciation

264.25

248.84

219.97

192.04

640.58

617.57

585.94

Profit Before Tax

606.69

489.97

272.53

206.68

636.31

201.53

330.23

Tax

142.59

134.37

56.51

35.87

35.80

27.22

15.38

Provisions and contingencies

0.00

Profit After Tax

464.10

355.60

216.02

170.81

600.51

174.31

314.85

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

5,071.20

6.88

315.90

0.00

Net Profit

464.10

5,426.80

222.90

486.71

600.51

174.31

314.85

Share in Profit of Associates

-37.00

-18.91

-11.34

-11.22

0.54

3.52

-0.19

Minority Interest

-38.96

-30.06

-82.28

-50.58

-75.06

-30.09

-38.05

Other related items

0.00

Consolidated Net Profit

388.14

5,377.83

129.28

424.91

525.99

147.74

276.61

Equity Capital

518.13

499.52

497.22

497.04

499.52

Face Value

10.0

Reserves

4,057.73

2,928.55

4,060.27

3,948.55

3,456.19

2,875.42

2,772.62

Earnings per share (EPS)

7.49

107.66

2.59

8.51

10.58

2.97

5.54

Diluted Earnings per share

7.52

107.85

2.6

8.53

10.57

2.97

5.5

Operating Profit Margin (Excl OI)

19.41%

18.47%

15.62%

15.0%

14.47%

12.35%

14.54%

Gross Profit Margin

18.76%

17.85%

13.31%

13.32%

12.45%

9.52%

10.59%

PAT Margin

9.2%

8.14%

5.53%

5.33%

5.86%

2.07%

3.64%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Annual Analysis Highlights

Net Sales

YoY Growth in year ended Mar 2026 is 12.20% vs 11.88% in Mar 2025

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is -92.78% vs 4,059.83% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 17.85% vs 32.28% in Mar 2025

Interest

YoY Growth in year ended Mar 2026 is -0.67% vs 12.25% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Compare Annual Results Of Aster DM Health. With

Select Peers

Figures in Cr

Consolidate Annual Results

Change(INR)

Change(%)

Net Sales

4,643.22

7,782.75

-3,139.53

-40.34%

Other Operating Income

0.00

Total Operating income

4,643.22

7,782.75

-3,139.53

-40.34%

Raw Material Cost

0.00

1,838.07

-1,838.07

-100.00%

Purchase of Finished goods

1,047.61

0.00

1,047.61

(Increase) / Decrease In Stocks

1.18

-7.88

9.06

114.97%

Employee Cost

848.09

1,167.24

-319.15

-27.34%

Power Cost

0.00

Manufacturing Expenses

27.52

1,630.62

-1,603.10

-98.31%

Selling and Distribution Expenses

1,031.87

0.00

1,031.87

Other Expenses

785.92

1,566.76

-780.84

-49.84%

Total Expenditure (Excl Depreciation)

3,742.19

6,194.81

-2,452.62

-39.59%

Operating Profit (PBDIT) excl Other Income

901.03

1,587.94

-686.91

-43.26%

Other Income

125.60

66.94

58.66

87.63%

Operating Profit (PBDIT)

1,026.63

1,654.88

-628.25

-37.96%

Interest

122.98

184.41

-61.43

-33.31%

Exceptional Items

-32.71

-89.34

56.63

63.39%

Gross Profit (PBDT)

870.94

1,381.13

-510.19

-36.94%

Depreciation

264.25

385.61

-121.36

-31.47%

Profit Before Tax

606.69

995.52

-388.83

-39.06%

Tax

142.59

197.66

-55.07

-27.86%

Provisions and contingencies

0.00

Profit After Tax

464.10

797.86

-333.76

-41.83%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

464.10

797.86

-333.76

-41.83%

Share in Profit of Associates

-37.00

11.52

-48.52

-421.18%

Minority Interest

-38.96

-35.17

-3.79

-10.78%

Other related items

0.00

Consolidated Net Profit

388.14

774.21

-386.07

-49.87%

Equity Capital

518.13

754.96

-236.83

-31.37%

Face Value

10.00

0.00

Reserves

4,057.73

8,161.56

-4,103.83

-50.28%

Earnings per share (EPS)

7.49

10.25

-2.76

-26.93%

Diluted Earnings per share

7.52

10.26

-2.74

-26.71%

Operating Profit Margin (Excl OI)

19.41%

20.40%

0.00

-0.99%

Gross Profit Margin

18.76%

17.75%

0.00

1.01%

PAT Margin

9.20%

10.40%

0.00

-1.20%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Annual - Net Sales

Net Sales 4,643.22 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is 12.20% vs 11.88% in Mar 2025

Annual - Consolidate Net Profit

Consolidate Net Profit 388.14 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is -92.78% vs 4,059.83% in Mar 2025

Annual - Operating Profit (PBDIT)

Operating Profit (PBDIT) 901.03 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is 17.85% vs 32.28% in Mar 2025

Annual - Interest

Interest 122.98 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is -0.67% vs 12.25% in Mar 2025

Annual - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 19.41%

in Mar 2026

Figures in %

YoY Growth in year ended Mar 2026 has improved from Mar 2025